[KYMR] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -6.05%
YoY- 2.28%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 25,650 16,513 11,514 18,519 3,288 67.06%
PBT -42,062 -38,799 -40,257 -24,660 -13,989 31.65%
Tax 0 4,632 -553 98 228 -
NP -42,062 -38,799 -39,704 -24,660 -13,989 31.65%
Tax Rate - - - - - -
Total Cost 67,712 55,312 51,218 43,179 17,277 40.66%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin -163.98 -234.96 -344.83 -133.16 -425.46 -21.19%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.58 -0.67 -0.77 -0.55 -0.32 16.01%
EPS Diluted -0.58 -0.67 -0.77 -0.55 -0.32 16.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.